Europe POCT Market – Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Publish Reports
  • Jun 2019
  • Europe
  • 215 Pages
  • No of Tables: 24
  • No of Figures: 132
Europe POCT Market By Device Type (Handheld and Bench Top), Product (cardio-metabolic monitoring, glucose monitoring, fertility and pregnancy, coagulation monitoring, infectious disease, hematology, tumor marker, urinalysis testing, cholesterol test, drug abuse testing, fecal occult testing and others), Diseases (cardiology, diabetes, gynecology, respiratory diseases, liver diseases and others), Prescription Mode (over the counter and prescription based), End User (laboratories, diagnostic centers, hospitals, home care settings, clinics and  ambulance service) and Country (Germany, U.K.,  France, Spain, Italy, Switzerland, Denmark, Belgium, Norway, Sweden, Netherlands, Russia, Turkey and Rest of Europe) – Industry Trends and Forecast to 2026 Point-of-care testing (POCT) is defined as the testing of samples taken from a patient and performed at or near the bedside, with the result leading to possible changes in the care of that individual. It is a diagnostic test which is conducted close to the site where clinical care needs to be delivered. POCT is often accomplished through the use of light, portable, and handheld instruments (blood glucose meter, INR meter). POCT is an alternative to central or core laboratory testing.

These tests are accomplished through the use of transportable, portable, and handheld instruments. Bench analysers are also available for the purpose of testing of pH, electrolyte, blood gas and haemoglobin measurement of the blood samples. Analysers are also available for rapid and accurate analysis of urine.

Europe POCT Market is projected to register a healthy CAGR in the forecast period of 2019 to 2026.

Segmentation: Europe POCT Market

Europe POCT Market is segmented into five notable segments that are device type, product, diseases, prescription mode and end user.

  • On the basis of device type, the market is segmented into Handheld and Bench Top devices.
  • On the basis of product, the market is segmented into cardio-metabolic monitoring, glucose monitoring, fertility and pregnancy, coagulation monitoring, infectious disease, hematology, tumor marker, urinalysis testing, cholesterol test, drug abuse testing, fecal occult testing and others.
  • On the basis of diseases, the market is segmented into cardiology, diabetes, gynecology, respiratory diseases, liver diseases and others.
  • On the basis of prescription mode, the market is segmented into over the counter and prescription based.

  • On the basis of end user, the market is segmented laboratories, diagnostic centers, hospitals, home care settings, clinics and ambulance service.

Competitive Analysis: Europe POCT Market

Some of the major players operating in this market are F. Hoffmann-La Roche Ltd., Siemens, Holigic Inc. Abaxis, Acon Laboratories, Inc., Randox Laboratories, Ltd., Danaher, Abott, Thermo Fisher Scientific, Inc., Trivitron Healthcare, Cavidi, Clarity Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Becton, Dickinson and Company, Nova Biomedical, Trinity Biotech, Chembio Diagnostic Systems, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Biomérieux SA., and others.

Product Launch

  • In February 2019, Hologic, Inc. announced the launch of their Business Intelligence Tool, Unifi Analytics, which is an essential tool for maximizing efficiency and reducing the downtime in the suite of mammography.
  • In February 2019, Siemens Healthineers announced an investment of USD 397.21 million in the new Campus Forchheim (Germany) transforming thelocation of Forchheim into Siemens Healthineers Campus. This will bring the company closer to its ambition of reshaping the future of healthcare.

Research Methodology: Europe POCT Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE OF CONTENTS EUROPE POCT MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF EUROPE POCT MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 DBMR TRIPOD DATA VALIDATION MODEL 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 SECONDARY SOURCES 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 TECHNOLOGICAL ADVANCEMENTS IN POCT DEVICES 3.1.2 INCREASED USAGE OF POCT DEVICES IN HOMECARE SETTINGS 3.1.3 RISING INCIDENCES OF CHRONIC DISEASES 3.1.4 GROWING DEMAND FOR WEARABLE DEVICES

3.2 RESTRAINTS

3.2.1 PRODUCT RECALLS: HAMPERING USER CONFIDENCE 3.2.2 RISING COST OF POCT DEVICES 3.2.3 UNFAVOURABLE REIMBURSEMENT SCENARIO

3.3 OPPORTUNITIES

3.3.1 POC TESTS WITH MULTIPLEXED CAPABILITIES 3.3.2 EMERGING MICROFLUIDIC LAB-ON–A–CHIP TECHNOLOGY

3.4 CHALLENGES

3.4.1 RELUCTANCE TOWARDS CHANGE IN EXISTING DIAGNOSTIC PRACTICES 3.4.2 LACK OF ACCURACY AND EFFICIENCY 3.4.3 DATA MANAGEMENT AND LACK OF CONNECTIVITY 3.4.4 TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

4 REGULATORY SCENARIO

4.1 OVERVIEW 4.2 REGULATORY PROCEDURE: 4.3 CE MARKING

5 REIMBURSEMENT SCENARIO

5.1 OVERVIEW

6 EXECUTIVE SUMMARY 7 PREMIUM INSIGHTS 8 KEY PRIMARY INSIGHTS 9 EUROPE POCT MARKET, BY DEVICE TYPE

9.1 OVERVIEW 9.2 HANDHELD 9.3 BENCH TOP

10 EUROPE POCT MARKET, BY PRODUCT

10.1 OVERVIEW 10.2 CARDIO-METABOLIC MONITORING

10.2.1 CARDIAC MARKERS 10.2.2 HB1AC TESTING 10.2.3 BLOOD GAS/ELECTROLYTES 10.2.4 LIPID TESTING

10.3 GLUCOSE MONITORING 10.4 FERTILITY AND PREGNANCY

10.4.1 PREGNANCY TESTING KITS 10.4.2 FERTILITY TESTING KITS

10.5 COAGULATION MONITORING

10.5.1 ACT/APTT TESTING 10.5.2 PT/INR TESTING

10.6 INFECTIOUS DISEASE

10.6.1 INFLUENZA/FLU POC 10.6.2 HIV POC 10.6.3 HEPATITIS C VIRUS (HCV) POC 10.6.4 STD TESTING 10.6.5 TROPICAL DISEASES TESTING 10.6.6 RESPIRATORY INFECTIONS TESTING 10.6.7 OTHER INFECTIOUS DISEASES

10.7 HEMATOLOGY 10.8 TUMOR MARKER 10.9 URINALYSIS TESTING 10.10 CHOLESTEROL TEST 10.11 DRUG ABUSE TESTING 10.12 FECAL OCCULT TESTING 10.13 OTHERS

11 EUROPE POCT MARKET, BY DISEASES

11.1 OVERVIEW 11.2 CARDIOLOGY 11.3 DIABETES 11.4 GYNAECOLOGY 11.5 RESPIRATORY DISEASES 11.6 LIVER DISEASES 11.7 OTHERS

12 EUROPE POCT MARKET, BY PRESCRIPTION MODE

12.1 OVERVIEW 12.2 PRESCRIPTION BASED 12.3 OVER THE COUNTER

13 EUROPE POCT MARKET, BY END-USER

13.1 OVERVIEW 13.2 LABORATORIES 13.3 DIAGNOSTIC CENTERS 13.4 HOSPITALS 13.5 HOME CARE SETTINGS 13.6 CLINICS 13.7 AMBULANCE SERVICE

14 EUROPE POCT MARKET, BY COUNTRY

14.1 EUROPE

14.1.1 GERMANY 14.1.2 U.K. 14.1.3 FRANCE 14.1.4 SPAIN 14.1.5 ITALY 14.1.6 SWITZERLAND 14.1.7 DENMARK 14.1.8 BELGIUM 14.1.9 NORWAY 14.1.10 SWEDEN 14.1.11 NETHERLANDS 14.1.12 RUSSIA 14.1.13 TURKEY 14.1.14 REST OF EUROPE

15 EUROPE POCT MARKET, COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: EUROPE

16 COMPANY PROFILES

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT 16.1.2 SWOT ANALYSIS 16.1.3 REVENUE ANALYSIS 16.1.4 GEOGRAPHICAL PRESENCE 16.1.5 PRODUCT PORTFOLIO 16.1.6 RECENT DEVELOPMENTS 16.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.2 F. HOFFMANN-LA ROCHE LTD.

16.2.1 COMPANY SNAPSHOT 16.2.2 SWOT ANALYSIS 16.2.3 REVENUE ANALYSIS 16.2.4 GEOGRAPHICAL PRESENCE 16.2.5 PRODUCT PORTFOLIO 16.2.6 RECENT DEVELOPMENTS 16.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.3 BIOMÉRIEUX SA

16.3.1 COMPANY SNAPSHOT 16.3.2 SWOT ANALYSIS 16.3.3 REVENUE ANALYSIS 16.3.4 GEOGRAPHICAL PRESENCE 16.3.5 PRODUCT PORTFOLIO 16.3.6 RECENT DEVELOPMENTS 16.3.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.4 SIEMENS

16.4.1 COMPANY SNAPSHOT 16.4.2 SWOT ANALYSIS 16.4.3 REVENUE ANALYSIS 16.4.4 GEOGRAPHICAL PRESENCE 16.4.5 PRODUCT PORTFOLIO 16.4.6 RECENT DEVELOPMENTS 16.4.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.5 DANAHER

16.5.1 COMPANY SNAPSHOT 16.5.2 SWOT ANALYSIS 16.5.3 REVENUE ANALYSIS 16.5.4 GEOGRAPHICAL PRESENCE 16.5.5 PRODUCT PORTFOLIO 16.5.6 RECENT DEVELOPMENTS 16.5.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.6 ABAXIS

16.6.1 COMPANY SNAPSHOT 16.6.2 GEOGRAPHICAL PRESENCE 16.6.3 PRODUCT PORTFOLIO 16.6.4 RECENT DEVELOPMENTS

16.7 ACON LABORATORIES, INC.

16.7.1 COMPANY SNAPSHOT 16.7.2 GEOGRAPHICAL PRESENCE 16.7.3 PRODUCT PORTFOLIO 16.7.4 RECENT DEVELOPMENTS

16.8 BECTON, DICKINSON AND COMPANY

16.8.1 COMPANY SNAPSHOT 16.8.2 REVENUE ANALYSIS 16.8.3 GEOGRAPHICAL PRESENCE 16.8.4 PRODUCT PORTFOLIO 16.8.5 RECENT DEVELOPMENTS

16.9 BIO-RAD LABORATORIES, INC.

16.9.1 COMPANY SNAPSHOT 16.9.2 REVENUE ANALYSIS 16.9.3 GEOGRAPHICAL PRESENCE 16.9.4 PRODUCT PORTFOLIO 16.9.5 RECENT DEVELOPMENT

16.10 CAVIDI

16.10.1 COMPANY SNAPSHOT 16.10.2 GEOGRAPHICAL PRESENCE 16.10.3 PRODUCT PORTFOLIO 16.10.4 RECENT DEVELOPMENTS

16.11 CHEMBIO DIAGNOSTIC SYSTEMS, INC.

16.11.1 COMPANY SNAPSHOT 16.11.2 REVENUE ANALYSIS 16.11.3 GEOGRAPHICAL PRESENCE 16.11.4 PRODUCT PORTFOLIO 16.11.5 RECENT DEVELOPMENTS

16.12 CLARITY DIAGNOSTICS

16.12.1 COMPANY SNAPSHOT 16.12.2 PRODUCT PORTFOLIO 16.12.3 RECENT DEVELOPMENT

16.13 HOLIGIC INC

16.13.1 COMPANY SNAPSHOT 16.13.2 REVENUE ANALYSIS 16.13.3 GEOGRAPHICAL PRESENCE 16.13.4 PRODUCT PORTFOLIO 16.13.5 RECENT DEVELOPMENTS

16.14 NOVA BIOMEDICAL

16.14.1 COMPANY SNAPSHOT 16.14.2 GEOGRAPHICAL PRESENCE 16.14.3 PRODUCT PORTFOLIO 16.14.4 RECENT DEVELOPMENTS

16.15 RANDOX LABORATORIES, LTD.

16.15.1 COMPANY SNAPSHOT 16.15.2 GEOGRAPHICAL PRESENCE 16.15.3 PRODUCT PORTFOLIO 16.15.4 RECENT DEVELOPMENTS

16.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

16.16.1 COMPANY SNAPSHOT 16.16.2 GEOGRAPHICAL PRESENCE 16.16.3 PRODUCT PORTFOLIO 16.16.4 RECENT DEVELOPMENTS

16.17 SYSMEX CORPORATION

16.17.1 COMPANY SNAPSHOT 16.17.2 REVENUE ANALYSIS 16.17.3 GEOGRAPHICAL PRESENCE 16.17.4 PRODUCT PORTFOLIO 16.17.5 RECENT DEVELOPMENTS

16.18 THERMO FISHER SCIENTIFIC, INC.

16.18.1 COMPANY SNAPSHOT 16.18.2 REVENUE ANALYSIS 16.18.3 GEOGRAPHICAL PRESENCE 16.18.4 PRODUCT PORTFOLIO 16.18.5 RECENT DEVELOPMENTS

16.19 TRINITY BIOTECH

16.19.1 COMPANY SNAPSHOT 16.19.2 REVENUE ANALYSIS 16.19.3 GEOGRAPHICAL PRESENCE 16.19.4 PRODUCT PORTFOLIO 16.19.5 RECENT DEVELOPMENTS

16.20 TRIVITRON HEALTHCARE

16.20.1 COMPANY SNAPSHOT 16.20.2 GEOGRAPHICAL PRESENCE 16.20.3 PRODUCT PORTFOLIO 16.20.4 RECENT DEVELOPMENTS

17 CONCLUSION 18 QUESTIONNAIRE 19 RELATED REPORTS

LIST OF TABLES EUROPE POCT MARKET

TABLE 1 SUMMARY OF REIMBURSEMENT IN EUROPEAN COUNTRIES FOR CRP POCT TABLE 2 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES TABLE 3 EUROPE POCT MARKET, BY DEVICE TYPE , 2017-2026 (USD MILLION) TABLE 4 EUROPE POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 5 EUROPE CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 6 EUROPE FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 7 EUROPE COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 8 CLIA-WAIVED TESTS FOR INFECTIOUS DISEASES TABLE 9 EUROPE INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 10 COMMERCIALLY AVAILABLE POC DEVICES FOR CANCER DETECTION TABLE 11 EUROPE POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 12 EUROPE POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 13 EUROPE POCT MARKET, BY END-USER , 2017-2026 (USD MILLION) TABLE 14 EUROPE POCT MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 15 GERMANY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 16 GERMANY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 17 GERMANY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 18 GERMANY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 19 GERMANY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 20 GERMANY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 21 GERMANY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 22 GERMANY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 23 GERMANY POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 24 U.K. POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 25 U.K. POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 26 U.K. CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 27 U.K. FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 28 U.K. COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 29 U.K. INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 30 U.K. POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 31 U.K. POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 32 U.K. POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 33 FRANCE POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 34 FRANCE POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 35 FRANCE CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 36 FRANCE FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 37 FRANCE COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 38 FRANCE INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 39 FRANCE POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 40 FRANCE POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 41 FRANCE POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 42 SPAIN POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 43 SPAIN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 44 SPAIN CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 45 SPAIN FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 46 SPAIN COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 47 SPAIN INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 48 SPAIN POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 49 SPAIN POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 50 SPAIN POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 51 ITALY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 52 ITALY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 53 ITALY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 54 ITALY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 55 ITALY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 56 ITALY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 57 ITALY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 58 ITALY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 59 ITALY POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 SWITZERLAND POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 61 SWITZERLAND POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 62 SWITZERLAND CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 63 SWITZERLAND FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 64 SWITZERLAND COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 65 SWITZERLAND INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 66 SWITZERLAND POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 67 SWITZERLAND POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 68 SWITZERLAND POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 69 DENMARK POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 70 DENMARK POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 71 DENMARK CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 72 DENMARK FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 73 DENMARK COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 74 DENMARK INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 75 DENMARK POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 76 DENMARK POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 77 DENMARK POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 78 BELGIUM POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 79 BELGIUM POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 80 BELGIUM CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 81 BELGIUM FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 82 BELGIUM COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 83 BELGIUM INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 84 BELGIUM POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 85 BELGIUM POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 86 BELGIUM POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 87 NORWAY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 88 NORWAY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 89 NORWAY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 90 NORWAY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 91 NORWAY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 92 NORWAY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 93 NORWAY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 94 NORWAY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 95 NORWAY POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 96 SWEDEN POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 97 SWEDEN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 98 SWEDEN CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 99 SWEDEN FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 100 SWEDEN COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 101 SWEDEN INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 102 SWEDEN POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 103 SWEDEN POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 104 SWEDEN POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 105 NETHERLANDS POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 106 NETHERLANDS POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 107 NETHERLANDS CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 108 NETHERLANDS FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 109 NETHERLANDS COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 110 NETHERLANDS INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 111 NETHERLANDS POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 112 NETHERLANDS POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 113 NETHERLANDS POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 114 RUSSIA POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 115 RUSSIA POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 116 RUSSIA CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 117 RUSSIA FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 118 RUSSIA COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 119 RUSSIA INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 120 RUSSIA POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 121 RUSSIA POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 122 RUSSIA POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 123 TURKEY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION) TABLE 124 TURKEY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 125 TURKEY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 126 TURKEY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 127 TURKEY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 128 TURKEY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION) TABLE 129 TURKEY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION) TABLE 130 TURKEY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION) TABLE 131 TURKEY POCT MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 132 REST OF EUROPE POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES EUROPE POCT MARKET

FIGURE 1 EUROPE POCT MARKET: SEGMENTATION FIGURE 2 EUROPE POCT MARKET : GEOGRAPHICAL SCOPE FIGURE 3 EUROPE POCT MARKET: DATA VALIDATION MARKET FIGURE 4 EUROPE POCT MARKET: DROC ANALYSIS FIGURE 5 EUROPE POCT MARKET: REGION VS COUNTRY ANALYSIS FIGURE 6 EUROPE POCT MARKET: COMPANY RESEARCH ANALYSIS FIGURE 7 EUROPE POCT MARKET: INTERVIEWS BY REGION AND DESIGNATION FIGURE 8 EUROPE POCT MARKET: DBMR MARKET POSITION GRID FIGURE 9 EUROPE POCT MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE POCT MARKET FIGURE 11 EUROPE POCT MARKET SEGMENTATION FIGURE 12 GROWING DEMAND OF WEARABLE DEVICES IS EXPECTED TO DRIVE THE MARKET FOR EUROPE POCT MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 FIGURE 13 CARDIO-METABOLIC MONITORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POCT MARKET IN 2019 & 2026 FIGURE 14 EUROPE POCT MARKET: BY DEVICE TYPE, 2018 FIGURE 15 EUROPE POCT MARKET: BY PRODUCT, 2018 FIGURE 16 EUROPE POCT MARKET: BY DISEASES, 2018 FIGURE 17 EUROPR POCT MARKET: BY PRESCRIPTION MODE, 2018 FIGURE 18 EUROPE POCT MARKET: BY END-USER, 2018 FIGURE 19 EUROPE POCT MARKET: SNAPSHOT (2018) FIGURE 20 EUROPE POCT MARKET: BY COUNTRY (2018) FIGURE 21 EUROPE POCT MARKET: BY COUNTRY (2019 & 2026) FIGURE 22 EUROPE POCT MARKET: BY COUNTRY (2018 & 2026) FIGURE 23 EUROPE POCT MARKET: BY DEVICE TYPE (2019 - 2026) FIGURE 24 EUROPE POCT MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART